This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mirchandani, D. Articles by Roy-Burman, P. Search for Related Content PubMed PubMed Citation Articles by Mirchandani, D. Articles by Roy-Burman, P.

American Journal of Pathology, Vol 147, 92-101, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer

D Mirchandani, J Zheng, GJ Miller, AK Ghosh, DK Shibata, RJ Cote and P Roy-Burman
Department of Pathology, University of Southern California School of Medicine, Los Angeles 90033, USA.

Prostatic carcinoma from 65 patients have been examined for the occurrence of point mutations in the p53 tumor suppressor gene locus within the region of exons 5 to 8. Overall, only a small fraction of tumors (12.3%) was found to contain p53 mutations. No significant correlation was detected between the presence of the mutant gene and either tumor volume or histopathological grade. However, metastatic prostatic tumors are found to display a higher percentage (21.4%) of p53 mutations compared with primary adenocarcinomas (9.8%). Analysis of the topographical distribution of the p53 mutant genotype revealed two remarkable findings. First, multifocal tumors within a prostate appear to differ in harboring the mutant gene, and second, evidence is obtained for intratumor heterogeneity in the distribution of the mutant p53 allele. Together these findings appear to explain, at least in part, why there has been a wide discrepancy in the reported detection frequency of p53 mutations in prostate cancer specimens. It appears that the outcome of mutation analysis would depend not only on which tumors but also which regions of the tumors are included in the study. Furthermore, the observed heterogeneous topographical distribution of the mutation, if confirmed to be unique to prostate cancer, may have important implications in the understanding of the biology of prostate carcinogenesis.

This article has been cited by other articles:

				A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones Carcinogenesis, February 1, 2006; 27(2): 216 - 224. [Abstract] [Full Text] [PDF]

				J. Gil, P. Kerai, M. Lleonart, D. Bernard, J. C. Cigudosa, G. Peters, A. Carnero, and D. Beach Immortalization of Primary Human Prostate Epithelial Cells by c-Myc Cancer Res., March 15, 2005; 65(6): 2179 - 2185. [Abstract] [Full Text] [PDF]

				X.-H. Liu, A. Kirschenbaum, K. Yu, S. Yao, and A. C. Levine Cyclooxygenase-2 Suppresses Hypoxia-induced Apoptosis via a Combination of Direct and Indirect Inhibition of p53 Activity in a Human Prostate Cancer Cell Line J. Biol. Chem., February 4, 2005; 280(5): 3817 - 3823. [Abstract] [Full Text] [PDF]

				C. Ren, L. Li, A. A. Goltsov, T. L. Timme, S. A. Tahir, J. Wang, L. Garza, A. C. Chinault, and T. C. Thompson mRTVP-1, a Novel p53 Target Gene with Proapoptotic Activities Mol. Cell. Biol., May 15, 2002; 22(10): 3345 - 3357. [Abstract] [Full Text] [PDF]

				J. R.M. van der Sijp, J. P.A.M. van Meerbeeck, A. P.W.M. Maat, P. E. Zondervan, H. F.B.M. Sleddens, A. N. van Geel, A. M.M. Eggermont, and W. N.M. Dinjens Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical Importance J. Clin. Oncol., February 15, 2002; 20(4): 1105 - 1114. [Abstract] [Full Text] [PDF]

				G. Narla, K. E. Heath, H. L. Reeves, D. Li, L. E. Giono, A. C. Kimmelman, M. J. Glucksman, J. Narla, F. J. Eng, A. M. Chan, et al. KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer Science, December 21, 2001; 294(5551): 2563 - 2566. [Abstract] [Full Text] [PDF]

				D. I. Quinn, S. M. Henshall, D. R. Head, D. Golovsky, J. D. Wilson, P. C. Brenner, J. J. Turner, W. Delprado, J. F. Finlayson, P. D. Stricker, et al. Prognostic Significance of p53 Nuclear Accumulation in Localized Prostate Cancer Treated with Radical Prostatectomy Cancer Res., March 1, 2000; 60(6): 1585 - 1594. [Abstract] [Full Text]

				S. T. Shi, G.-Y. Yang, L.-D. Wang, Z. Xue, B. Feng, W. Ding, E. P. Xing, and C. S. Yang Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions Carcinogenesis, April 1, 1999; 20(4): 591 - 597. [Abstract] [Full Text] [PDF]

				E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]

				J. Serth, F. Panitz, U. Paeslack, M. A. Kuczyk, and U. Jonas Increased Levels of Human Papillomavirus Type 16 DNA in a Subset of Prostate Cancers Cancer Res., February 1, 1999; 59(4): 823 - 825. [Abstract] [Full Text] [PDF]

				S. L. Sugg, S. Ezzat, I. B. Rosen, J. L. Freeman, and S. L. Asa Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid Neoplasia J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4116 - 4122. [Abstract] [Full Text]